Next report date
Report period
Q1 2024
EPS estimate
−0.24TWD
Revenue estimate
110.00 MTWD
−1.30TWD
−156.33 MTWD
109.91 MTWD
About BIOGEND THERAPEUTICS CO LTD
Sector
Headquarters
Taipei
Website
Founded
2016
ISIN
TW0006733009
FIGI
BBG00PDLB2R7
BioGend Therapeutics Co., Ltd. engages in the development of medical equipment to restore bone and joint functions. Its products include bioactive bone graft material, biphasic cartilage repair implant and biological aggregates. The company was founded on July 7, 2016 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6733 is 36.80 TWD — it has increased by 0.82% in the past 24 hours. Watch BIOGEND THERAPEUTICS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BIOGEND THERAPEUTICS CO LTD stocks are traded under the ticker 6733.
BIOGEND THERAPEUTICS CO LTD is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6733 stock is 1.37% volatile and has beta coefficient of 0.39. Track BIOGEND THERAPEUTICS CO LTD stock price on the chart and check out the list of the most volatile stocks — is BIOGEND THERAPEUTICS CO LTD there?
Yes, you can track BIOGEND THERAPEUTICS CO LTD financials in yearly and quarterly reports right on TradingView.
6733 stock has risen by 0.27% compared to the previous week, the month change is a 2.90% fall, over the last year BIOGEND THERAPEUTICS CO LTD has showed a 6.84% decrease.
6733 net income for the last quarter is −32.71 M TWD, while the quarter before that showed −42.37 M TWD of net income which accounts for 22.80% change. Track more BIOGEND THERAPEUTICS CO LTD financial stats to get the full picture.
Today BIOGEND THERAPEUTICS CO LTD has the market capitalization of 4.49 B, it has decreased by 1.91% over the last week.
No, 6733 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6733 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOGEND THERAPEUTICS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
6733 reached its all-time high on Jul 9, 2020 with the price of 63.35 TWD, and its all-time low was 14.55 TWD and was reached on Mar 19, 2020. View more price dynamics on 6733 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOGEND THERAPEUTICS CO LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOGEND THERAPEUTICS CO LTD stock shows the neutral signal. See more of BIOGEND THERAPEUTICS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOGEND THERAPEUTICS CO LTD future price: according to them, 6733 price has a max estimate of 48.00 TWD and a min estimate of 48.00 TWD. Watch 6733 chart and read a more detailed BIOGEND THERAPEUTICS CO LTD stock forecast: see what analysts think of BIOGEND THERAPEUTICS CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOGEND THERAPEUTICS CO LTD EBITDA is −121.53 M TWD, and current EBITDA margin is −110.57%. See more stats in BIOGEND THERAPEUTICS CO LTD financial statements.